Comments
Loading...
ITeos Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ITOS | Benzinga
ITeos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-1.000
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$35.00M
Analyze the earnings history of ITeos Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ITOS | ITeos Therapeutics | -$1.07 | -$1.00 | — | — | $0.00 | — | — | — | 05/09/2025 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.85 | -$1.02 | -$1.01 | 0.98% | $0.00 | — | $0.00 | — | 03/05/2025 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.90 | -$0.89 | -$1.05 | -17.98% | $0.00 | — | $0.00 | — | 11/12/2024 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.96 | -$1.04 | -$0.18 | 82.69% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.44 | -$1.26 | -$1.07 | 15.08% | $12.60M | — | $0.00 | — | 05/10/2024 | Get Alert |
| ITOS | ITeos Therapeutics | $0.54 | -$1.03 | -$0.85 | 17.48% | $53.91K | — | $0.00 | — | 03/06/2024 | Get Alert |
| ITOS | ITeos Therapeutics | $0.03 | -$1.20 | -$0.90 | 25.00% | $19.49M | — | $0.00 | — | 11/07/2023 | Get Alert |
| ITOS | ITeos Therapeutics | $0.15 | -$1.03 | -$0.96 | 6.80% | $41.72M | — | $0.00 | — | 08/08/2023 | Get Alert |
| ITOS | ITeos Therapeutics | $1.82 | -$0.99 | -$0.44 | 55.56% | $152.52M | $8.04M | $12.60M | 56.65% | 05/10/2023 | Get Alert |
| ITOS | ITeos Therapeutics | $4.88 | $0.33 | $0.54 | 63.64% | — | — | $53.91K | — | 03/15/2023 | Get Alert |
| ITOS | ITeos Therapeutics | $1.86 | $0.10 | $0.03 | -70.00% | $104.27M | $42.05M | $19.49M | -53.66% | 11/10/2022 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.75 | $1.20 | $0.15 | -87.50% | $0.00 | $85.56M | $41.72M | -51.24% | 08/10/2022 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.39 | — | $1.82 | — | $0.00 | — | $152.52M | — | 05/12/2022 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.43 | $1.28 | $4.88 | 281.25% | $0.00 | — | $240.50M | — | 03/23/2022 | Get Alert |
| ITOS | ITeos Therapeutics | -$0.48 | — | $1.86 | — | $0.00 | $161.12M | $104.27M | -35.28% | 11/10/2021 | Get Alert |
| ITOS | ITeos Therapeutics | -$29.49 | -$0.41 | -$0.75 | -82.93% | $0.00 | $3.91M | $0.00 | -100.00% | 08/12/2021 | Get Alert |
| ITOS | ITeos Therapeutics | — | -$0.48 | -$0.39 | 18.75% | — | — | $0.00 | — | 05/13/2021 | Get Alert |
| ITOS | ITeos Therapeutics | — | — | -$0.43 | — | — | — | $0.00 | — | 03/24/2021 | Get Alert |
| ITOS | ITeos Therapeutics | -$43.03 | — | -$0.48 | — | — | — | $0.00 | — | 11/12/2020 | Get Alert |
| ITOS | ITeos Therapeutics | -$36.49 | — | -$29.49 | — | — | — | $0.00 | — | 09/01/2020 | Get Alert |
ITeos Therapeutics (ITOS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-05 | $-1.01 | $-1.02 | 0.98 % |
| Q3 | 2024-11-12 | $-1.05 | $-0.89 | -18.0 % |
| Q2 | 2024-08-08 | $-0.18 | $-1.04 | 82.7 % |
| Q1 | 2024-05-10 | $-1.07 | $-1.26 | 15.1 % |
ITeos Therapeutics (ITOS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2023-05-10 | $12.60M | $8.04M | 56.6 % |
| Q3 | 2022-11-10 | $19.49M | $42.05M | -53.7 % |
| Q2 | 2022-08-10 | $41.72M | $85.56M | -51.2 % |
| Q3 | 2021-11-10 | $104.27M | $161.12M | -35.3 % |
FAQ
When is ITeos Therapeutics (NASDAQ:ITOS) reporting earnings?
ITeos Therapeutics (ITOS) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on March 5, 2025 for Q4.
What were the latest earnings per share (EPS) for ITeos Therapeutics (NASDAQ:ITOS)?
The Actual EPS was $-1.01, which beat the estimate of $-1.02.
What were ITeos Therapeutics’s (NASDAQ:ITOS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.